Reducing LDL cholesterol by 25-40% over five years lowers the chance of dying from coronary heart disease or having a heart attack by 20-35%, whether the reduction comes from statins, diet, surgery, or other treatments.
See the scientific wording
A 25-40% reduction in low-density lipoprotein cholesterol over five years reduces the risk of coronary heart disease death or non-fatal myocardial infarction by approximately 20-35% in both primary and secondary prevention populations, regardless of the method used to lower LDL-C.
Very strong evidence
One moderate-quality study supports this claim, so treat this as an early signal rather than settled science.
What the research says
1 study reviewedSupporting (1)
Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis.
Systematic Review With Meta-AnalysisMeta-analysis2005
This study found that lowering bad cholesterol by any method — whether with pills, diet, or surgery — reduces heart disease risk by about the same amount: for every 1% drop in cholesterol, heart risk drops 1%. This means the cholesterol drop itself is what helps, not other effects of the drugs.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
When too much LDL cholesterol circulates in the blood, it enters the walls of arteries and builds up as fatty deposits. These deposits attract immune cells that turn into foam cells, forming hard plaques that narrow the arteries. When plaques rupture, they cause blood clots that block blood flow to the heart, leading to heart attacks or death.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Reducing LDL cholesterol by 25-40% over five years lowers the chance of dying from coronary heart disease or having a heart attack by 20-35%, whether the reduction comes from statins, diet, surgery, or other treatments.
Mechanism
1 studyToo much LDL cholesterol gets stuck in artery walls and turns into fatty plaques. These plaques grow, harden, and sometimes burst, causing clots that block blood flow to the heart. Lowering LDL cholesterol stops this process before it starts, preventing heart attacks and death.
When too much LDL cholesterol circulates in the blood, it enters the walls of arteries and builds up as fatty deposits. These deposits attract immune cells that turn into foam cells, forming hard plaques that narrow the arteries. When plaques rupture, they cause blood clots that block blood flow to the heart, leading to heart attacks or death.
Excess low-density lipoprotein cholesterol particles penetrate the endothelial lining of coronary arteries and become trapped in the subendothelial space.
Trapped LDL particles undergo oxidative modification, triggering an inflammatory response that recruits monocytes into the arterial wall.
Monocytes differentiate into macrophages that engulf oxidized LDL particles, becoming lipid-laden foam cells that accumulate and form fatty streaks.
Foam cell death and continued lipid deposition lead to the formation of a necrotic core surrounded by a fibrous cap, creating an atherosclerotic plaque.
Plaque growth narrows the arterial lumen, reducing blood flow to cardiac muscle, and plaque rupture exposes thrombogenic material to the bloodstream.
Exposed plaque contents activate platelets and the coagulation cascade, forming an occlusive thrombus that blocks coronary blood flow.
Coronary occlusion causes myocardial ischemia, leading to cardiomyocyte death and non-fatal myocardial infarction or sudden cardiac death.
Evidence from Studies
Supporting (1)
Community contributions welcome
Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis.
This study found that lowering bad cholesterol by any method — whether with pills, diet, or surgery — reduces heart disease risk by about the same amount: for every 1% drop in cholesterol, heart risk drops 1%. This means the cholesterol drop itself is what helps, not other effects of the drugs.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of LDL-C Lowering Interventions on Cardiovascular Mortality and Non-Fatal MI in Primary and Secondary Prevention
Population: Adults in primary and secondary prevention; Intervention: LDL-C reduction of 25-40% via statins, diet, bile acid sequestrants, or ileal bypass; Comparator: No LDL-C reduction or minimal reduction; Outcome: Coronary heart disease death or non-fatal myocardial infarction; Duration: Minimum five years.
Randomized Trial Comparing LDL-C Reduction via Statins vs. Diet vs. Surgery on Cardiovascular Events Over Five Years
Population: Adults with elevated LDL-C in primary and secondary prevention; Intervention: Four arms—statins, dietary change, bile acid sequestrants, ileal bypass—all targeting 25-40% LDL-C reduction; Comparator: Placebo or minimal intervention; Outcome: Composite of coronary heart disease death or non-fatal myocardial infarction; Duration: Five years; Design: Double-blind, stratified by prevention type.
Prospective Cohort Study of LDL-C Reduction Methods and Long-Term Cardiovascular Outcomes in Diverse Populations
Population: Large cohort of adults with baseline LDL-C >100 mg/dL; Intervention: Natural variation in LDL-C reduction via statins, diet, surgery, or no treatment; Comparator: Groups with <25% LDL-C reduction; Outcome: Coronary heart disease death or non-fatal myocardial infarction; Duration: Five years or longer; Follow-up: Annual LDL-C and outcome assessment.
Case-Control Study of Individuals with and without Coronary Events Following LDL-C Reduction of 25-40% Over Five Years
Population: Cases with coronary heart disease death or non-fatal MI; Controls without such events; Exposure: Historical LDL-C reduction of 25-40% over five years via any method; Comparator: Cases vs. controls with <25% LDL-C reduction; Duration: Retrospective five-year exposure window; Data source: Medical records.
Cross-Sectional Analysis of LDL-C Levels and Prevalence of Coronary Events in a Population Sample
Population: Representative sample of adults; Exposure: Single measurement of LDL-C reduction status (25-40% reduction over five years inferred from history); Outcome: Self-reported or recorded history of coronary heart disease death or non-fatal MI; Duration: Single time point; Design: Survey and medical record review.